➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
Boehringer Ingelheim
Dow
McKesson
Harvard Business School

Last Updated: May 27, 2020

DrugPatentWatch Database Preview

Litigation Details for DAIICHI PHARMACEUTIC v. APOTEX INC. (D.N.J. 2003)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

DAIICHI PHARMACEUTIC v. APOTEX INC. (D.N.J. 2003)

Docket   Start Trial Date Filed 2003-03-04
Court District Court, D. New Jersey Date Terminated 2009-05-19
Cause 35:271 Patent Infringement Assigned To Susan Davis Wigenton
Jury Demand Defendant Referred To Madeline Cox Arleo
Parties APOTEX CORP.; APOTEX INC.; DAIICHI SANKYO CO., LTD; DAIICHI SANKYO, INC.
Patents 4,382,892; 4,551,456; 4,844,902; 5,053,407; 5,401,741
Attorneys JAMES P. FLYNN; STEVEN GERBER
Firms Schoeman Updike Kaufman & Gerber LLP
Link to Docket External link to docket
Small Molecule Drugs cited in DAIICHI PHARMACEUTIC v. APOTEX INC.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for DAIICHI PHARMACEUTIC v. APOTEX INC. (D.N.J. 2003)

Date Filed Document No. Description Snippet Link To Document
2005-11-01 124 Opinion prosecution of Daiichi’s U.S. Patent No. 5,401,741 (“the ‘741 patent”). Apotex’s arguments…the field of patent law. Mr. Killworth has over 35 years’ experience in patent law as a… Customs and Patent Appeals, and as a registered patent attorney. Kidd Decl., Exhibit A. …Mr. Killworth has limited experience at the U.S. Patent and Trademark Office (“PTO”) and that he is … a patent examiner, law clerk and technical advisor to Judge Almond of the United States Court of Customs External link to document
2005-11-01 128 Opinion during the prosecution of its U.S. Patent No. 5,401,741 (“the ‘741 patent”), entitled a “Topical Preparation…that an erroneous publication date for another patent provided in Daiichi’s Information Disclosure … The IDS disclosed the existence of a German patent identified as DE 3,632,222 (“Grohe ‘222”) and… qualified to testify as an expert in Patent and Trademark Office practice and procedure …it prior to submitting it to the United States Patent and Trademark Office (“PTO”). Based on Mr External link to document
2005-11-01 130 Opinion alleging patent infringement of all seven claims of Daiichi’s U.S. Patent No. 5,401,741 (“the ‘741… to a patent unless... (f) he did not himself invent the subject matter sought to be patented....” …failing to name the proper inventors of Daiichi’s patent pursuant to 35 U.S.C. § 102(f). For…‘741 patent”), entitled a “Topical Preparation for Treating Otopathy.” Daiichi now argues that… defense that it is not entitled to the ‘741 patent for failure to name the proper inventors pursuant External link to document
2006-03-28 165 Letter U.S. Patent 5,401,741. (Attachments: # 1 Stipulation Concerning Claim 3 of U.S. Patent 5,401,741)(FLYNN… 2003 19 May 2009 2:03-cv-00937 830 Patent Defendant District Court, D. External link to document
2006-07-21 180 Stipulation and Order STIPULATION AND ORDER concerning Claim 3 of U.S. patent No. 5,401,741. Signed by Judge William G. Bassler on 7… 2003 19 May 2009 2:03-cv-00937 830 Patent Defendant District Court, D. External link to document
2006-07-21 181 Opinion alleging that Apotex infringed Daiichi’s U.S. Patent No. 5,401,741. After the culmination of the nine day…. Hedden, 149 U.S. 304, 306 (1893)). In patent cases, however, where the definition of a term … 415 F.3d 1303, 1319 (Fed. Cir. 2005). Patent cases are complex suits that often hinge on the…Supreme Court, has held that disputed terms in a patent suit are to be determined as a matter of law.…often resolves disputes concerning terms in a patent during a pre-trial “Markman” hearing. Id. External link to document
2006-07-25 183 Opinion alleging that Apotex infringed Daiichi’s U.S. Patent No. 5,401,741. Daiichi served its First Set of Interrogatories…by Apotex that any of claims 1-7 of Daiichi’s patent-in-suit is invalid . . . .” (Daiichi’s…number of prior art exhibits in support of their patent invalidity defense, which are currently the subject…documents that they alleged to be prior art of the patent-in-suit. The Court conditionally admitted the…contested exhibits and to show their relevancy to the patent-in-suit. Unlike the usual bench trial External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
AstraZeneca
McKinsey
Mallinckrodt
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.